Literature DB >> 21311403

Distribution of three antituberculous drugs and their metabolites in different parts of pathological vertebrae with spinal tuberculosis.

Peng Liu1, Qingan Zhu, Jianming Jiang.   

Abstract

STUDY
DESIGN: To detect drug concentration levels and metabolite using high-performance liquid chromatography.
OBJECTIVE: To map concentration levels of three antituberculous drugs and two metabolites in the abnormal osseous tissues around the foci of patients with spinal tuberculosis. SUMMARY OF BACKGROUND DATA: Concentration levels of antituberculous drugs in the focus of spinal tuberculosis has been reported. However, the mapping of drugs distribution in different regions surrounding the foci of tuberculosis vertebrae remains unexplored, as well as the metabolite of the drugs.
METHODS: Thirty-eight patients with spinal tuberculosis were assigned into sclerotic group (n = 13) and nonsclerotic group (n = 25) based on computed tomographic (CT) images. All patients received a chemotherapy 10 months with 2HRZE/8H(2)R(2)E(2). All patients received surgery after 4 weeks of chemotherapy. Samples of serum, ilium, and pathologic vertebral tissues, including the foci, sclerotic wall (if applicable), region I of abnormal osseous tissues (within 4 mm), and region II of abnormal osseous tissues (more than 4 mm) from the foci were collected during operation. Concentration levels and metabolite of three drugs were measured using high-performance liquid method for all samples. Differences of means within groups were evaluated by ANOVA and Dunnett post hoc. A significant levels was set at P < 0.05.
RESULTS: Concentration levels of drugs varied greatly in different regions of spinal tuberculosis vertebrae. Concentration levels of isoniazid and rifampin were higher than the effective bactericidal concentration (EBC) level and that of pyrazinamide was five times of the minimal inhibitory concentration in the region II of abnormal osseous tissues and the ilium of nonsclerotic group. Three drugs achieved EBC in the region I of abnormal osseous tissues in the nonsclerotic group but not in the sclerotic group. Except pyrazinamide no drugs and their metabolite were identified in the foci of the sclerotic group, whereas there is trace of drugs and their metabolite in the foci of the nonsclerotic group.
CONCLUSION: Three drugs resulted in an effective bactericidal concentration level in osseous tissues around the foci of spinal tuberculosis except the osseous tissues 4 mm surrounding the sclerotic wall. The results suggested that osseous tissues within 4 mm surrounding the sclerotic wall should be excised during the surgery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21311403     DOI: 10.1097/BRS.0b013e31820beae3

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  10 in total

1.  Is duration of preoperative anti-tuberculosis treatment a risk factor for postoperative relapse or non-healing of spinal tuberculosis?

Authors:  Hai-Long Ren; Jian-Ming Jiang; Ji-Xing Wang; Dong-Bin Qu; Jian-Ting Chen
Journal:  Eur Spine J       Date:  2016-03-07       Impact factor: 3.134

Review 2.  Spinal tuberculosis: a review.

Authors:  Ravindra Kumar Garg; Dilip Singh Somvanshi
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

Review 3.  A comparative study of one-stage posterior unilateral limited laminectomy vs. bilateral laminectomy debridement and bone grafting fusion combined with internal fixation for the treatment of aged patients with single-segment spinal tuberculosis.

Authors:  Liyuan Jiang; Xiaolong Sheng; Zhansheng Deng; Qile Gao; Shaohua Liu
Journal:  BMC Musculoskelet Disord       Date:  2022-06-28       Impact factor: 2.562

4.  One-stage surgical treatment for thoracic and lumbar Spinal tuberculosis by transpedicular fixation, debridement, and combined interbody and posterior fusion via a posterior-only approach.

Authors:  Bing Ran; Yuan-Long Xie; Lei Yan; Lin Cai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

5.  Correlation between Serum Level of Monocyte Chemoattractant Protein-1 and Postoperative Recurrence of Spinal Tuberculosis in the Chinese Han Population.

Authors:  Dan He; Xiaolu Zhang; Qile Gao; Rongfu Huang; Zhansheng Deng; Chaofeng Guo; Qiang Guo; Jia Huang; Hongqi Zhang
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

6.  One-Stage Anterolateral Debridement, Bone Grafting, and Internal Fixation for Treating Lumbosacral Tuberculosis.

Authors:  Tao Zhang; Lihua Ma; Xu Lan; Ping Zhen; Shiyong Wang; Zhilin Li
Journal:  Asian Spine J       Date:  2017-04-12

7.  Submuscular gluteal abcess: An unusual presentation of rare sacral tuberculosis.

Authors:  Yoshi Pratama Djaja; Phedy Phedy; Jamot Silitonga; Didik Librianto; Ifran Saleh
Journal:  Int J Surg Case Rep       Date:  2018-11-24

8.  A biphasic nanohydroxyapatite/calcium sulphate carrier containing Rifampicin and Isoniazid for local delivery gives sustained and effective antibiotic release and prevents biofilm formation.

Authors:  Irfan Qayoom; Rahul Verma; Prem Anand Murugan; Deepak Bushan Raina; Arun Kumar Teotia; Saravanan Matheshwaran; Nisanth N Nair; Magnus Tägil; Lars Lidgren; Ashok Kumar
Journal:  Sci Rep       Date:  2020-08-24       Impact factor: 4.379

9.  A comparative study to evaluate the feasibility of preoperative percutaneous catheter drainage for the treatment of lumbar spinal tuberculosis with psoas abscess.

Authors:  Zhen Lai; Shiyuan Shi; Jun Fei; Guihe Han; Shengping Hu
Journal:  J Orthop Surg Res       Date:  2018-11-19       Impact factor: 2.359

Review 10.  Challenges and controversies in the treatment of spinal tuberculosis.

Authors:  Aakriti Pandita; Nikhil Madhuripan; Saptak Pandita; Rocio M Hurtado
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-02-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.